The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in ...
The FDA’s new draft guidance on Bayesian methods in clinical trials has been hailed by some as a breakthrough that could speed drug development. But statisticians and researchers are divided on ...
In the ultracompetitive world of drug development, getting a new medication on the market as fast as possible can have major ...
This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. When Sarepta Therapeutics revealed this month that a ...
Vinay Prasad, M.D., is out again as the chief medical and scientific officer for the U.S. Food and Drug Administration (FDA).
A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to serve everyone fairly. Only 6% of the clinical trials that backed new ...
COPENHAGEN (Reuters) -Novo Nordisk's closely watched Alzheimer's trials of an older oral version of its semaglutide drug failed to help slow the progression of the brain-wasting disease, the firm said ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Brain organoids allow researchers to personalize testing medications Psychiatric drug ...